Bharat Biotech ’s plant in Karnataka to produce its first batch of Covaxin next month
The Hyderabad-based vaccine and bio-therapeutics firm has repurposed its veterinary vaccine plant at Malur industrial area near Bengaluru to produce Covaxin. The Union government had announced a support of Rs 65 crore for this plant to accelerate production of indigenous Covid-19 vaccines.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | COVID-19 | Government | Pharmaceuticals | Vaccines | Veterinary Research | Veterinary Vaccinations